GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Medicine

Immunology

Pathology

Show all topics

DOI

10.1101/2022.05.01.490250

License

cc-no